Robert Wesolowski

Robert Wesolowski, MD

  • Medical Oncology

Appointments: (614) 293-0066

About Me

I am a medical oncologist who specializes in treating patients diagnosed with breast cancer.

My clinical specialties include female and male breast cancers, breast cancer immunology, ductal breast carcinomas, lobular carcinomas, medullary carcinomas, hereditary breast and ovarian cancer syndrome, and inflammatory breast cancers.

My research focuses on breast cancer immunology. I study the interaction of the immune system with cancer with the goal of improving and expanding the use of immunotherapies to shrink tumors. In the laboratory, we are researching ways to inhibit or destroy myeloid-derived suppressor cells in hopes of boosting antitumor immune response in patients with cancer. We are also testing combinations of therapies that could inhibit myeloid-derived suppressor cells and increase the killing ability of T cells. Our goal is to develop the best therapies that can be tested in patients with breast and other cancers.

In addition to treating patients and conducting laboratory research. I am a principal investigator on several phase I trials that test promising therapies in patients with breast cancer and other solid tumors.

In 2013, 2015, 2016 and 2017, I was recognized as a high-performing physician at The Ohio State University Wexner Medical Center based on patient-satisfaction scores and I was also listed among the top 10 percent of physicians who achieved highest patient satisfaction on a national level in 2013 and 2015. In 2013 I received the Physician "Champion of Nursing" Excellence Award from the OSUCCC – James. I am honored to be a Courage, Conquer & Cure Foundation Award recipient for showing dedication to breast cancer research and outstanding patient care. In addition, I was recognized as central Ohio’s best doctors of 2015-2016 and 2017-2018 in medical oncology and hematology, a listing that appeared in Columbus Business First in October 2015 and 2017.

Highlights

  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016
  • Best Doctor in America 2017

Additional languages I speak

  • Polish

Specialties and conditions I treat

  • Medical Oncology
  • Breast Cancer
  • Carcinoma, Ductal, Breast
  • Carcinoma, Ductal
  • Hereditary Breast and Ovarian Cancer Syndrome
  • Carcinoma, Lobular
  • Male Breast Cancer
  • Inflammatory Breast Cancers
  • Carcinoma, Medullary

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

Education and training

Medical Degree

M.D.
SUNY Downstate Medical College
4/23/2004

Residency

Internal Medicine
Cleveland Clinic Foundation
7/1/2005 - 6/30/2007

More about my work

My background

Fellowship

Hematology/Oncology
Cleveland Clinic Foundation
7/1/2007 - 6/30/2010

Board Certifications

American Board of Internal Medicine
8/20/2007

American Board of Internal Medicine (Subspecialty: Medicine Oncology)
11/10/2010

My Department

Internal Medicine

My Division

Medical Oncology

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/28/2017, Dr. Wesolowski has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.

  • Novartis
  • Agenus Pharmaceuticals
  • Helsinn